Humana has made a strategic equity investment in Livongo Health, a consumer digital health company that is empowering people with chronic diseases. The equity investment will support Livongo’s growth and help accelerate the launch of new diabetes management products and services.
In the first phase of their partnership, Humana has made Livongo available to a select group of its members with successful results—delivering access to integrated diabetes management that combines consumer-focused technology with personalized coaching.
Humana’s strategic investment completes Livongo’s $49.5 million Series C financing round and brings the total amount raised to more than $82.5M.
“Our industry’s continued shift to value-based care provides impetus for everyone to work together to reinvent healthcare, and our partnership with Livongo Health is a direct example of how collaboration between companies can work to move the needle,” said Sarah Ahmad, Vice President and Head of Innovation’s consumer health solutions at Humana.